MedPAC Recommends Policies for Reducing Part B Drug Spending, Additional Site-Neutral Payments
- June 16, 2023
The Medicare Payment Advisory Commission (MedPAC) in its latest report to Congress recommended several new policies for reducing spending growth on Part B drugs and biologics, which rose 9% annually on average from 2009 to 2021.
ARTICLE TAGS
You must be logged in to access this content.